UMB Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

UMB Bank’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.19K	Buy	300 +217	+261%	+$2.97K	﹤0.01%	2091
2026 Q1	$1.03K	Buy	+83	New	+$1.11K	﹤0.01%	2214

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

UMB Bank's AMRX Position: Q2 2026 in Review

UMB Bank increased its Amneal Pharmaceuticals (AMRX) stake by 261% in Q2 2026, buying an estimated $2.97K and bringing the position to 300 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

UMB Bank first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

UMB Bank held 300 shares of Amneal Pharmaceuticals worth $5.19K as of Q2 2026.
UMB Bank bought 217 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.97K.
Amneal Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2091 holding.
UMB Bank first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.